Exercise of Share Options & Total Voting Rights

IDOX PLC
09 February 2024
 

Idox plc

('Idox' or the 'Group' or the 'Company')

Exercise of Share Options &

Total Voting Rights

 

Idox plc (AIM: IDOX) a leading supplier of specialist information management software and solutions to the public and asset-intensive sectors, announces that it has issued 423,395 new ordinary shares of 1 pence each in the Company ("Ordinary Shares") pursuant to an exercise of options by employees under its Idox plc Long Term Incentive Plans.

An application has been made for the 423,395 new Ordinary Shares to be admitted to trading on AIM ("Admission"). It is expected that Admission will occur at 8.00 a.m. on or around 12th February 2024.

The Company holds no ordinary shares in treasury. The total number of ordinary shares in issue following Admission will be 456,938,906. Therefore, the total number of ordinary shares with voting rights in the Company will be 456,938,906.

The above figure of 456,938,906 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure and Transparency Rules.

 

Enquiries:

Idox plc

+44 (0) 870 333 7101

Chris Stone, Non-Executive Chairman

David Meaden, Chief Executive

Anoop Kang, Chief Financial Officer

 

 

 

Peel Hunt LLP (NOMAD and Broker)

+44 (0) 20 7418 8900

Paul Gillam

Michael Burke

Adam Telling

 

 

 

MHP Group

+44 (0) 203 128 8100

Reg Hoare

Ollie Hoare

Matthew Taylor 

idox@mhpgroup.com

 

 

 

About Idox plc For more information see www.idoxplc.com @Idoxgroup

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 

Companies

IDOX (IDOX)
UK 100

Latest directors dealings